Skip to main content
Fig. 1 | BMC Nephrology

Fig. 1

From: Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities

Fig. 1

Proportion of patients using submaximal or maximal dosage of RAASi divided by indication

Patients with hypertension, diabetic kidney disease and coronary heart disease most often used maximal dosage RAASi. DKD, diabetic kidney disease; CHD, coronary heart disease; TIA/CVA, cerebrovascular disease; HT, hypertension; smRAASi, use of submaximal dosage RAASi; mRAASi, use of maximal dosage RAASi

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us